ERSP Press Releases

ERSP Continues to Expand its Review Program

ERSP reported on recent activity under an expanded program to review advertising claims made for lead-generation businesses, as well as the review of telemarketing scripts and calls by companies participating in its new Telemarketing Review Program.

Read More

ERSP Finds Migralex, Inc. Provided Reasonable Basis for Advertising Claims

ERSP has determined that Migralex, Inc. can support performance and establishment claims for Migralex, an over-the-counter product intended for the treatment of headaches.

Read More

ERSP Finds Farr Laboratories, Inc. Can Support Performance Claims for ‘Prosta-Q,’ Recommends Marketer Modify Certain Claims

ERSP determined that Farr Laboratories, LLC can support general performance claims for Prosta-Q, a dietary supplement intended to address the symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), but recommended certain changes.

Read More

ERSP Finds Lonza America Provided Reasonable Basis for Immune System Claims; Recommends Modification to Establishment Claims

ERSP has recommended that Lonza America, Inc., modify certain “clinically” proven claims for the company’s “Alomune” dietary supplement.

Read More

ERSP Refers Advertising for Internet Secrets to FTC for Further Review After Marketer Fails to Respond to ERSP Inquiry

ERSP will refer direct response advertising for The 7 Day Test Affiliate Marketing Program to the Federal Trade Commission (FTC) after the marketer, Internet Secrets, failed to respond to an ERSP inquiry.

Read More

ERSP Refers Advertising for Hazel Peppergood Work-at-Home System to FTC for Further Review After Marketer Fails to Respond to ERSP Inquiry

ERSP will refer direct response advertising for Hazel Peppergood Work-at-Home System to the Federal Trade Commission (FTC) after the marketer, Hazel Peppergood, Inc., failed to respond to an ERSP inquiry.

Read More